Growth Metrics

Tvardi Therapeutics (TVRD) Change in Acquisitions & Divestments (2016 - 2025)

Tvardi Therapeutics' Change in Acquisitions & Divestments history spans 10 years, with the latest figure at $5.0 million for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments changed 0.0% to $5.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.8 million, a 78.23% decrease, with the full-year FY2025 number at $21.4 million, down 73.9% from a year prior.
  • Change in Acquisitions & Divestments hit $5.0 million in Q4 2025 for Tvardi Therapeutics, down from $5.3 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for TVRD hit a ceiling of $59.0 million in Q1 2024 and a floor of $1.0 million in Q2 2021.
  • Historically, Change in Acquisitions & Divestments has averaged $24.0 million across 5 years, with a median of $15.5 million in 2024.
  • Biggest five-year swings in Change in Acquisitions & Divestments: soared 448.01% in 2022 and later crashed 94.6% in 2024.
  • Tracing TVRD's Change in Acquisitions & Divestments over 5 years: stood at $1.0 million in 2021, then skyrocketed by 5725.0% to $58.2 million in 2022, then tumbled by 36.74% to $36.9 million in 2023, then plummeted by 86.43% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for TVRD at $5.0 million in Q4 2025, $5.3 million in Q3 2025, and $5.0 million in Q4 2024.